The SRF documentary on Medical Cannabis provides an overview on the current market situation Key takeouts: good results on patients using the medicine high prices for patient due to 1 company dominant position flowers are not yet available as medicine (it will only be available with the #pilotprojects medical Cannabis still need to evolve from…
On February 1st 2022, the Swiss Association of Cantonal Chemists, announced in a press release that, in Switzerland, the vast majority of products sold containing the cannabis extract cannabidiol (CBD) do not meet legal requirements. It was relayed across many media channels, such as swissinfo stating that Most CBD cannabis products fail to meet standards. However, these findings do not apply to the medical/therapeutic cannabis.
This week, in his radio programme “On va vers le beau“, Jonas Schneiter meets people who are working for sustainable solutions by developing different projects related to the production and transformation of hemp in Switzerland. Whether it is in the production of CBD, medicines, fashion or construction, he questions the role, the possibilities and the…
No products in the cart.